Hyperlipidemia

Search with Google Search with Bing
Information
Disease name
Hyperlipidemia
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT02262806 Active, not recruiting Phase 2 Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy October 14, 2014 July 31, 2025
NCT05535660 Active, not recruiting Lipid Profile as Predictor of Adverse Maternal and Neonatal Outcomes: A Pilot Study July 29, 2022 October 2024
NCT00934258 Available Effect of Genes on Rosuvastatin Therapy for Hyperlipidemia
NCT00059254 Completed N/A Differential Metabolism of Dietary Fatty Acids September 2000 April 2005
NCT00069524 Completed Phase 1/Phase 2 Antihyperlipidemic Effects of Oyster Mushrooms June 2004 May 2006
NCT00072891 Completed N/A Improving Medication Adherence in Comorbid Conditions December 2005
NCT00090402 Completed Phase 1/Phase 2 Fish Oil and Alpha Lipoic Acid in Treating Alzheimer's Disease April 2004 August 2007
NCT00093899 Completed Phase 3 A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED) November 2004 September 2005
NCT00106236 Completed Phase 1/Phase 2 Efficacy of Exercise at a Fitness Club for Cardiovascular Risk Reduction April 2003 April 2004
NCT00108459 Completed Phase 3 Low Carbohydrate Diet Compared to Calorie and Fat Restricted Diet in Patients With Obesity and Type II Diabetes September 2004 December 2007
NCT00109603 Completed N/A Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy May 2005 November 2007
NCT00114855 Completed N/A The Effect of Hypocol® on Lipids in Subjects With Mild Hypercholesterolemia and Mildly Elevated Blood Glucose March 2005 June 2006
NCT00117494 Completed Phase 4 Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) (ANRS126) October 2005 June 2007
NCT00123435 Completed N/A Veterans Walk for Health Study July 2005 June 2009
NCT00127751 Completed Phase 2 Heart Disease on the Mend May 2000 May 2003
NCT00134173 Completed Phase 3 A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease October 2003 September 2006
NCT00134485 Completed Phase 3 Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia March 2005 March 2006
NCT00136942 Completed Phase 3 A Swiss Study With Atorvastatin in Hyperlipidemic Patients Measuring LDL-Cholesterol April 2005
NCT00136981 Completed Phase 3 Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrpib/Atorvastatin to Atorvastatin Alone. December 2003 November 2006
NCT00137462 Completed Phase 3 Lipitor Trial To Study The Effect Of Torcetrpib/Atorvastatin To Atorvastatin Alone. November 2004 September 2006
NCT00138762 Completed Phase 3 A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol July 2004 August 2006
NCT00139061 Completed Phase 3 Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate March 2005 May 2006
NCT00143234 Completed Phase 3 Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels May 2004 July 2005
NCT00147251 Completed Phase 4 Stop Atherosclerosis in Native Diabetics Study May 2003 May 1, 2007
NCT00157638 Completed Phase 4 Integrating Family Medicine and Pharmacy to Advance Primary Care Therapeutics February 2004 July 2006
NCT00160329 Completed Phase 3 Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia January 2004 March 2009
NCT00172419 Completed N/A The Effects of Atorvastatin on Vulnerable Plaques in Untreated Dyslipidemic Patients. March 2007 December 2008
NCT00174304 Completed Phase 4 Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia. October 2004 September 2006
NCT00174330 Completed Phase 4 Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia May 2005 February 2006
NCT00184951 Completed Phase 2 Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients April 2004 July 2005
NCT00194428 Completed Phase 1/Phase 2 Weight and Metabolic Effects of an Almond Enriched Hypocaloric, Low Fat Diet on Overweight and Obese Persons February 2005 October 2009
NCT00195793 Completed Phase 3 A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin August 2004
NCT00200993 Completed Phase 2 Peripheral Effects of Exercise on Cardiovascular Health (STRRIDE I) September 1998 April 2009
NCT00202241 Completed N/A The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDS September 1999 June 2001
NCT00203476 Completed Phase 4 A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction May 2005 January 2008
NCT00211705 Completed Phase 4 Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese(MEGA Study) February 1994 March 2004
NCT00222833 Completed Phase 4 The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With Schizophrenia October 2004 December 2005
NCT00225017 Completed Phase 3 Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study June 2005 June 2008
NCT00225628 Completed N/A Improving Quality With Outpatient Decision Support September 2000 December 2006
NCT02951962 Completed Phase 1 A Study to Investigate Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin August 2016 September 2016
NCT00001154 Completed Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins September 3, 1976
NCT00006493 Completed Phase 2 Rosiglitazone in the Treatment of HIV-Associated Hyperlipidemia
NCT01886326 Completed N/A Eating Peanuts for Health February 2010 May 2012
NCT01890226 Completed N/A A Mobile Personal Health Record for Behavioral Health Homes November 2014 January 2019
NCT01914432 Completed Phase 3 Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia November 2013 June 2014
NCT01918332 Completed Phase 3 Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and Hyperlipidemia April 2012 March 2013
NCT01918358 Completed Phase 1 Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Valsartan) Film-coated Tablet 160 mg and Crestor® (Rosuvastatin) 20 mg December 2012 January 2013
NCT01968954 Completed Phase 3 Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events October 2013 April 2016
NCT01968967 Completed Phase 3 Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events October 29, 2013 July 10, 2017
NCT01984424 Completed Phase 3 Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-3 December 10, 2013 November 21, 2017
NCT02012855 Completed N/A Effect of Different Types of Carbohydrates Consumed After Exercise on Blood Fat Levels August 2013 August 2015
NCT02029989 Completed N/A Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness February 2010 February 2012
NCT02044627 Completed Phase 1 Single Radiolabeled Dose Study to Investigate the Absorption, Metabolism and Excretion of [14C]-ETC-1002 December 2013 January 2014
NCT02047175 Completed Phase 1 CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin) February 2014 March 2014
NCT02100514 Completed Phase 3 Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events October 28, 2014 July 10, 2017
NCT02116517 Completed Phase 3 Effects of Green Tea Extract on Obese Women With High Level of LDL August 2011 December 2013
NCT02135029 Completed Phase 3 Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins June 2014 November 2015
NCT02153073 Completed Evaluation of the Safety and Efficacy of Long-term Use of Omega-3 Fatty Acid Ethyl Esters May 29, 2013 May 31, 2017
NCT02186483 Completed Phase 1 Clinical Trial to Investigate the Pharmacokinetics Drug Interaction Between Metformin and Rosuvastatin August 2014 February 2015
NCT02187757 Completed Phase 3 Study to Evaluate Efficacy and Safety of PreLipid® on Subjects With Higher Than Normal Blood Lipid Levels November 2013 November 2014
NCT02215408 Completed N/A MEDication Focused Outpatient Care for Underutilization of Secondary Prevention January 20, 2015 September 30, 2018
NCT02275156 Completed Phase 1 Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab August 19, 2014 December 19, 2014
NCT02278471 Completed Phase 2 The SCCS Polypill Pilot Trial December 2015 June 27, 2018
NCT02280590 Completed Phase 4 Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia September 2014
NCT02285166 Completed Specified Drug-use Survey of the Granular Capsule Formulation of Omega-3 Fatty Acid Ethyl Esters: OCEAN3 October 21, 2014 July 14, 2020
NCT02341664 Completed Patient and Provider Assessment of Lipid Management Registry May 2015 February 2016
NCT02366156 Completed N/A A 12 Week, 3-Period Study to Evaluate the Effects of a Dietary Supplement on Lipid Metabolism July 2014 March 2015
NCT02387619 Completed Phase 1 The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine February 2015 July 2015
NCT02388633 Completed Acute Microvascular Changes With LDL Apheresis March 1, 2015 July 1, 2018
NCT02428998 Completed N/A Safety for 24 Weeks Intake of Korean Red Ginseng in Adults September 2014 April 2017
NCT02433288 Completed N/A Rosuvastatin Adherence App Study in China July 20, 2015 October 28, 2016
NCT02437084 Completed Phase 4 Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling May 2015 April 2020
NCT02449187 Completed Phase 1 Investigate the Effect of Food on the Pharmacokinetics of JLP-1310 in Healthy Male Volunteers August 2, 2017 March 9, 2018
NCT02451098 Completed Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 March 2015 January 2016
NCT02458287 Completed Phase 3 Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or Dyslipidemia June 2015 February 2016
NCT02506920 Completed N/A Gender Dependent Difference in Lipemia After 6 x OFTT in Young Healthy Subjects January 1997 December 1997
NCT02511418 Completed N/A Renal Hemodynamic Effects of the HMG-CoA Reductase Inhibitors in Normal Volunteers and in Patients With Chronic Renal Failure
NCT02512276 Completed N/A Tele-Pharmacy Intervention to Improve Treatment Adherence August 2015 October 2017
NCT02566187 Completed Phase 1 A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination Tablet August 2015 October 2015
NCT02569814 Completed Phase 1 A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin September 2015 December 2015
NCT02582424 Completed N/A Safety and Efficacy of PDL-0101 in Patients With Hyperlipidemias: a Pilot Study. July 2012 September 2013
NCT02593032 Completed N/A Effects of Use of a Connected Pillbox On Medication Adherence February 2015 September 21, 2017
NCT02596087 Completed N/A Improving Quality by Maintaining Accurate Problems in the EHR April 2016
NCT02611102 Completed N/A Effect of Butter & MCT Oil on Lipoproteins - A RCT March 8, 2016 March 2022
NCT02634034 Completed Phase 1 A Comparison Study to Evaluate the Pharmacokinetics and Safety of NK-104-CR in Healthy Adult Volunteers December 2015 December 2015
NCT02659397 Completed Phase 2 A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg December 2015 July 2016
NCT02676596 Completed Phase 1 Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of K-312 in Healthy Subjects April 2014 January 2015
NCT02730390 Completed Study on the Efficacy and Safety of Oral Probucol Tablets in Patients With Hyperlipidemia - Post-Marketing Surveillance December 2009 August 2013
NCT02742545 Completed N/A Impact of MayoExpertAdvisor on Provider Adherence April 2016 November 2016
NCT02742597 Completed N/A Patient-Centred Innovations for Persons With Multimorbidity - Ontario January 12, 2016 October 19, 2022
NCT02789800 Completed N/A Patient-Centred Innovations for Persons With Multimorbidity - Quebec April 22, 2016 November 1, 2022
NCT02824432 Completed Phase 4 Exploratory Study of the Effect of Omega-3-acid Ethyl Esters (TAK-085) on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated Dilation August 4, 2016 August 19, 2017
NCT02839382 Completed N/A The Northwest Coalition for Primary Care Practice Support May 1, 2015 May 1, 2018
NCT02839902 Completed Phase 4 Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood December 27, 2016 August 30, 2017
NCT02899455 Completed Phase 3 Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and Dyslipidemia July 2014 June 2016
NCT02905448 Completed N/A Low Fat Plant-Based Supplemented Diet Effects on Risk Factors for Chronic Non-communicable Diseases January 2016 July 2017
NCT02927184 Completed Phase 2 Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease September 28, 2016 March 26, 2019
NCT02942602 Completed N/A Effect of Lipid Modifying Drugs on HDL Function in Patients With Hyperlipidemia April 3, 2014 May 23, 2016
NCT00001142 Completed Metabolism and Body Shape of Healthy Children and Children With Chronic Infections October 1999 December 2000
NCT02982798 Completed Phase 1 The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers July 6, 2017 January 31, 2018
NCT03067688 Completed Phase 3 Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia April 11, 2017 March 27, 2018
NCT03116516 Completed Phase 1 Clinical Trial to Compare the Safety and Pharmacokinetics of YHP1604 in Comparison to the Co-administration of Telmisartan/Amlodipine and Rosuvastatin April 21, 2017 May 26, 2017
NCT03141827 Completed Phase 2/Phase 3 The Effect of Intranasal Insulin on Hepatic and Intestinal Triglyceride-rich Lipoprotein Production April 14, 2016 April 26, 2017
NCT03213288 Completed N/A Bilberry Fruit and Black Rice Derived Anthocyanins on Lipid Status September 25, 2017 September 30, 2018
NCT03225157 Completed Hearing Loss and the Effects of Statin Drugs in People With Head and Neck Squamous Cell Carcinoma Treated With Cisplatin Chemoradiation November 3, 2017 February 28, 2020
NCT03332641 Completed N/A Effect of Intake of Citron(Citrus Junos Siebold ex Tanaka) Peel Extract on Blood Cholesterol. June 7, 2017 September 28, 2017
NCT03657472 Completed Phase 1 Bioequivalence Study of CJ-30061 in Healthy Male Volunteers September 19, 2016 November 9, 2016
NCT03689946 Completed Phase 3 Effect of Evolocumab on Coronary Artery Plaque Volume and Composition by CCTA and Microcalcification by F18-NaF PET March 19, 2019 May 30, 2023
NCT03748420 Completed N/A Medication Adherence Clinical Decision Support August 19, 2020 January 31, 2023
NCT03944109 Completed Phase 1/Phase 2 The Safety, Tolerability and Efficacy of Multiple Subcutaneous Injections of SHR-1209 in Subjects With Hyperlipidemia June 20, 2019 December 22, 2020
NCT04457024 Completed Tennis Elbow Patients Undergoing Closed Therapy Can Easily Cause Tendon Tear January 1, 2020 April 1, 2020
NCT04640012 Completed Phase 1 Ascending-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics of DC371739 Single-Dose Treatment in Healthy Subjects September 25, 2020 March 15, 2022
NCT04672278 Completed N/A Lipid-Lowering Effect and Hypotensive Effect of Shanzha Fruit Drink in Patients January 2, 2019 October 30, 2020
NCT04673721 Completed N/A PROSPective Evaluation of Fortified Eggs Related to Improvement in The Biomarker Profile for Your Health January 6, 2021 December 13, 2022
NCT04686994 Completed Phase 1 Study to Evaluate the Safety and Efficacy of ASC41 in Overweight and Obese Subjects December 22, 2020 February 7, 2021
NCT04692025 Completed Phase 1 Study to Evaluate the Effect of Food on the Pharmacokinetics of ASC41 in Healthy Volunteers December 27, 2020 January 21, 2021
NCT04774003 Completed Phase 1 Study of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inclisiran in Chinese Participants With Elevated Serum LDL-C February 26, 2021 October 18, 2021
NCT04977583 Completed N/A Unmet Social Needs Study May 2, 2022 December 15, 2023
NCT06002893 Completed N/A The Antihypercholestrolemic Effect of a Combined Nutritional Supplementation of Standardized Extracts of Amla, Walnut, Red Yeast Rice and Olive March 19, 2020 July 31, 2023
NCT00236210 Completed N/A A Randomized Controlled Trial of a Novel Community-based Primary and Secondary Cardiovascular Prevention Program August 2004 July 2006
NCT00244231 Completed Phase 3 Efficacy and Safety Study of Nidadd in the Management of Hyperlipidemia October 2003 August 2005
NCT00246376 Completed N/A Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia January 2004 February 2012
NCT00246402 Completed N/A Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV September 2002 August 2006
NCT00249938 Completed Phase 4 Evaluation of Combination Cholesterol Treatments in Patients With High Cholesterol. March 2005 August 2006
NCT00255216 Completed N/A Policosanol for the Treatment of Hypercholesterolemia January 2005 August 2005
NCT00267254 Completed Phase 3 A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol. January 2006 August 2006
NCT00272402 Completed N/A Reducing Clinical Inertia in Diabetes Care February 2006 December 2009
NCT00275145 Completed Phase 2 Effects of Resistance and Aerobic Exercise on Cardiovascular Health May 2004 December 2008
NCT00296400 Completed Phase 2 Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease February 2006 June 2009
NCT00308386 Completed Phase 3 DYNAMIC Study: (Diabetes Nurse Case Management And Motivational Interviewing for Change) August 10, 2006 July 27, 2011
NCT00345657 Completed Phase 4 Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care July 2003 May 2004
NCT00345722 Completed Phase 2 The Effect of Strawberries in a Cholesterol-Lowering Dietary Portfolio June 2006 February 2007
NCT00349375 Completed Phase 3 Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin Monotherapy November 2005 September 2008
NCT00360217 Completed N/A The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes January 2006 May 2007
NCT00362206 Completed Phase 3 Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin September 2006 September 2008
NCT00362934 Completed Phase 3 Comparison of the Combination of Fenofibrate and Simvastatin Versus Atorvastatin October 2006 August 2008
NCT00365742 Completed N/A Statin Therapy Vs. Therapeutic Lifestyle Changes and Supplements April 2006 June 2006
NCT00376584 Completed Phase 3 Effect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED) July 2006 January 2007
NCT00378833 Completed Phase 3 Tolerability of MK0524A Versus Niacin Extended-Release (0524A-054) July 2006 March 2007
NCT00381992 Completed Risk Assessment of Long-Haul Truck Drivers September 2005 March 2010
NCT00382564 Completed Magnetic Resonance Angiography to Diagnose Atherosclerotic Disease September 25, 2006 May 1, 2012
NCT00386971 Completed N/A Effects of L-Carnitine on Postprandial Clearance of Triglyceride-rich Lipoproteins in HIV Patients on HAART October 2006 December 2009
NCT00393419 Completed N/A Federal Study of Adherence to Medications in the Elderly (FAME) June 2004 August 2006
NCT00405769 Completed N/A Lipid Lowering in Patients With Statin Intolerance January 2007 October 2007
NCT00414986 Completed N/A Using Learning Teams for Reflective Adaptation for Diabetes and Depression September 2005 February 2012
NCT00430430 Completed Phase 2 Lipoprotein Turnover on Low- and High-MUFA Portfolio Diets April 2007 April 2009
NCT00438425 Completed N/A Portfolio 5 - Multicentre Dietary Advice on Serum Lipids in Hyperlipidemia June 25, 2007 March 31, 2010
NCT00438893 Completed N/A Effects of a Long Term Dietary Portfolio and of Sequential Removal of Food Components From the Diet September 1, 2003 May 2009
NCT00451464 Completed Studies of Apolipoprotein Genotyping on the Drug Treatment of Hyperlipidemic Patients January 2002 January 2005
NCT00451828 Completed Phase 4 Cholesterol and Pharmacogenetic Study March 2002
NCT00457262 Completed N/A Effects of Soy Protein on Serum paraoxonase1 Activity and Lipoproteins in Postmenopausal Women January 2006 August 2006
NCT00465088 Completed Phase 3 An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME) April 2007
NCT00469365 Completed Phase 3 Pharmacy Interventions to Improve Chronic Disease Medication Refill January 2006 August 2006
NCT00473655 Completed Phase 4 Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients January 2007 February 2009
NCT00481299 Completed Insulin Resistance in Women With Prolactinoma October 2004 September 2006
NCT00484419 Completed Phase 3 Effects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabetes Patients Whose Blood Glucose Isn't Completely Controlled With Metformin May 2007 April 2008
NCT00490672 Completed Phase 4 Community Based Multiple Risk Factors Intervention Strategy August 2007 January 2009
NCT00507520 Completed Phase 2 Almond Dose Response Study. December 1999 September 2001
NCT00516204 Completed Diabetic Under 70 (Diabetics Below 70) July 2007 December 2007
NCT00516594 Completed Phase 2 The Effect of Altering Colonic Microflora After Fiber (FOS) Consumption
NCT00534105 Completed Lipid Metabolism in Gestational Diabetes September 2007 November 2010
NCT00536510 Completed Phase 3 Effect of MK0524A on Cholesterol Levels (0524A-048) April 2007 March 2008
NCT00552747 Completed Phase 4 Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL)in Patients With Coronary Heart Disease October 2007 January 2011
NCT00559962 Completed Phase 2 Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS October 2007 November 2008
NCT00565292 Completed Phase 1 A Study of MK0859 in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia (MK-0859-011)(COMPLETED) July 2006 August 2006
NCT00566267 Completed Phase 2/Phase 3 A Randomized, Double-Blinded Study of Simvastatin 20 mg/Day Versus Vytorin 10/20 in Subjects With Lipid Profiles Not Meeting Current NCEP Guidelines, Following a Low-Carbohydrate Diet April 2006 November 2007
NCT00569959 Completed N/A Assessment of Non-Fasting vs. Fasting Lipid Measures in Diabetes Patients November 2006 June 2007
NCT00593632 Completed N/A A Controlled Trial of High Dietary Fiber Intake on Serum Lipids January 2008 July 2013
NCT00603590 Completed Phase 2 Phase II Study of Heart Polypill Safety and Efficacy in Primary Prevention of Cardiovascular Disease November 2006 July 2008
NCT00603876 Completed Phase 4 Efficacy of Almonds Added to Chronic Statin Therapy July 2008 December 2012
NCT00628524 Completed Homburg Cream & Sugar Study February 2008 August 2013
NCT00630734 Completed Phase 4 Genetic Predictors of Variability in the Drug-drug Interaction Between Darunavir/Ritonavir and Pravastatin February 2008 September 2010
NCT00634608 Completed N/A Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow February 2008 September 2009
NCT00635544 Completed N/A Cross-Over Multicentre Study in Adolescents January 2007 April 2008
NCT00651560 Completed Phase 3 Vytorin As Strategy To Reduce Dislipidemia In Adults (0653A-148) November 1, 2005 December 23, 2005
NCT00652431 Completed Phase 1 Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2) May 2007 July 2007
NCT00654459 Completed Effects of Armolipid Plus on Cholesterol Levels and Endothelial Function July 2007 April 2008
NCT00669500 Completed N/A Body Worlds 3 Nutrition Display July 2007 March 2008
NCT00685737 Completed Phase 1 Safety of a Hypolipidemic Agent in Healthy Normal Volunteers December 2007 June 2008
NCT00701454 Completed Survey of Thai-Muslim Health Status September 2005 April 2006
NCT00701883 Completed Phase 2 Safety and Benefit of MBX-8025 With and Without Commonly Used Statins in Moderately Overweight Patients With High Cholesterol August 2007 August 2008
NCT00713167 Completed Phase 2/Phase 3 The Efficacy of Red Grape Seed Extract on Lipid Profile and Oxidized Low-Density Lipoprotein (OX-LDL) July 2008 February 2009
NCT00723723 Completed Compliance With LDL-Lowering Therapy (Study P05467)(COMPLETED) January 2008 June 2009
NCT00749801 Completed N/A Efficacy and Safety of Geneferm Nattokinase May 2007 April 2008
NCT00753883 Completed Phase 4 Ezetrol Post-Marketing Study July 2006
NCT00756405 Completed N/A Effects of Dietary Antioxidants on Cardiovascular Risk Factors March 2007 December 2008
NCT00758303 Completed Phase 2/Phase 3 A Study to Evaluate the Lipid Regulating Effects of TRIA-662 September 2007 December 2008
NCT00778804 Completed N/A Preventing Heart Disease in Underserved Patients July 2004 February 2007
NCT00781560 Completed Awareness of Chinese National Adult Lipid Treatment Guideline (2007) and Rate of Patients Achieving the Treatment Goal October 2008 July 2009
NCT00787306 Completed Phase 3 Cardiovascular Health And Risk Modification in Family Health Teams October 2008 June 2009
NCT00810979 Completed Phase 2 Comparison of SLx-4090 Combined With Statin Therapy Versus Statin Alone in Reducing LDL-C in Patients With Hyperlipidemia January 2009 September 2009
NCT00823277 Completed Metabolic Syndrome and Gen-polymorphs Influence on Weightloss Among Children in Treatment for Overweight January 2009 August 2012
NCT00828945 Completed Compliance With Treatment For Patients With Hyperlipidemia February 2009 March 2011
NCT00846300 Completed N/A A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas August 2001 May 2003
NCT00877825 Completed Phase 2 The Influence of Soy Isoflavnoids on the Hypocholesterolemic Effects of Soy April 2000
NCT00882336 Completed European Study of Cardiovascular Risk May 2009 October 2009
NCT00887653 Completed Phase 3 Changes in Lipids and Safety of Raltegravir in HIV+ Patients With Hyperlipidemia While on Current Standard Therapy May 2009 April 2014
NCT00891124 Completed Effect of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol). May 2009 October 2009
NCT00897975 Completed Phase 2/Phase 3 Red Yeast Rice and Phytosterols In Statin Intolerance July 2009 July 2011
NCT00910988 Completed N/A Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone February 2009 June 2012
NCT00917878 Completed N/A Postprandial Effects of Milk and Milk Constituents March 2009 July 2009
NCT00955227 Completed N/A Can Cholesterol Lowering Drugs Influence Circulating Omega-3 Fatty Acid Levels July 2009 December 2015
NCT00955903 Completed Phase 3 Calorie Restriction and Changes in Body Composition, Disease, Function, and Quality of Life in Older Adults June 2010 August 2014
NCT00973115 Completed Phase 3 Efficacy and Safety of Morning Versus Evening Intake of Simvast Controlled Release (CR) Tablet in Patients With Hyperlipidemia November 2007 August 2009
NCT01023607 Completed Phase 4 Evaluation of Statin-induced Lipid-rich Plaque Progression by Optical Coherence Tomography (OCT) Combined With Intravascular Ultrasound (IVUS) December 2009 August 2013
NCT01026103 Completed N/A Tri Staple Technology Stapler Used in Gastric Bypass January 2010 March 2011
NCT01033513 Completed SOS Nutrition Project May 2003 September 22, 2006
NCT01046968 Completed Phase 1/Phase 2 Lepticore in Metabolic Syndrome and Weight Loss August 2009 November 2009
NCT01047280 Completed Phase 1 Use of Conjugated Linoleic Acid as a Nutraceutical for Weight Loss in Humans November 2006 May 2009
NCT01050465 Completed N/A MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use May 2009 December 2010
NCT01056549 Completed N/A Exenatide (Byetta ®) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in Humans January 2010 September 2011
NCT01089231 Completed Phase 4 Effects of Omega-3 Fatty Acids on the Human Gene Expression March 2010 July 2011
NCT01099176 Completed N/A Effects of Hypolipemic Treatment on Adipokines May 2008 September 2009
NCT01122394 Completed N/A Reducing Risk of Recurrence January 2010 June 2015
NCT01131832 Completed Phase 4 Genetic Basis for Heterogeneity in Response of Plasma Lipids to Plant Sterols September 2010 February 2012
NCT01133522 Completed Phase 1 Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Evolocumab (AMG 145) in Adults With Hyperlipidemia on Stable Doses of a Statin June 1, 2010 September 14, 2011
NCT01142908 Completed N/A Cardiovascular Intervention Improvement Telemedicine Study November 1, 2011 May 22, 2015
NCT01145742 Completed N/A Controlling Hypertension in Diabetes- Feasibility Study November 2006 September 2009
NCT01152073 Completed N/A A Study Of Nutraceutical Drinks For Cholesterol (Evaluating Effectiveness and Tolerability) October 2009 September 2010
NCT01212159 Completed Phase 4 Telephone Based Management of Hyperlipidemia November 2010 August 2015
NCT01220336 Completed N/A Study of Medical Assistant Health Coaching in Primary Care for Patients With Chronic Conditions April 2011 June 2014
NCT01228032 Completed Phase 3 The Health Outcomes Management and Evaluation (HOME) Study April 2010 December 2015
NCT01235832 Completed N/A The Effect of Avocado on Cardiovascular Disease (CVD) Risk Factors November 2010 February 2013
NCT01236430 Completed Phase 1 A Study to Determine the Bioequivalence of SCH 900068 Compared to Marketed Products (Protocol No. P07551) February 2011 February 2012
NCT01239004 Completed Phase 4 Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy November 2010 August 2011
NCT01267227 Completed Phase 2/Phase 3 Effect of Pterostilbene on Cholesterol, Blood Pressure and Oxidative Stress December 2010 February 2012
NCT01275300 Completed N/A Biosynthesis of PGD2 in Vivo July 2007 January 2012
NCT01279590 Completed Phase 2 Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM) March 2011 November 2011
NCT01308710 Completed Phase 1 The Effects of a Mediterranean Diet in Pediatric Hyperlipidemia January 2010 July 2011
NCT01326442 Completed Phase 3 Vitamin D and Omega-3 Inhibit Metabolic Syndrome April 2011 December 2012
NCT01327014 Completed Phase 2 Efficacy and Safety Study of Lipid-Lowering Effects of XueZhiKang (XZK) in Patients With Hyperlipidemia April 2011 December 2012
NCT01332747 Completed Phase 2 Clinical Study to Evaluate Antihyperlipidemic Effect of a Classical Unani Antiobesity Formulation May 2010 May 2011
NCT01349010 Completed Phase 3 Efficacy and Safety of Imported Probucol to Treat Hyperlipidemia April 2011 February 2013
NCT01353404 Completed Phase 1 Relative Bioavailability Study of Lipidil® Supra (Fenofibrate 160mg) Versus SYO-0805 (Fenofibrate 65mg) June 2011 August 2011
NCT01360567 Completed Phase 3 The Effect of Green Tea Extract on Type 2 Diabetes With Hyperlipidemia May 2011 December 2012
NCT01375764 Completed Phase 2 Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects July 28, 2011 May 8, 2012
NCT01375777 Completed Phase 2 Monoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid Levels July 6, 2011 March 2, 2012
NCT01377064 Completed Phase 1 Home-based Exercise for Management of HIV-associated Cardiovascular Disease Risk March 2011 July 2013
NCT01380730 Completed Phase 2 LAPLACE-TIMI 57: Low-density Lipoprotein Cholesterol (LDL-C) Assessment With PCSK9 monoclonaL Antibody Inhibition Combined With Statin thErapy July 1, 2011 April 5, 2012
NCT01391585 Completed N/A Expanding Comparative Effectiveness Research (CER) Capability Through Complex Patient Relationship Management June 2011 August 2012
NCT01402102 Completed Phase 2/Phase 3 A Human Trial to Evaluate the Efficacy and Safety of Aged Garlic Powder on Improvement of Blood Lipids in Subjects With Hyperlipidemia July 2010 July 2011
NCT01406431 Completed Phase 1 Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects August 2011 October 2012
NCT01414803 Completed Phase 4 Tolerability and Efficacy of Rosuvastatin - Fenofibrate Combine Therapy in Korean Patients With Combined Hyperlipidemia March 2009 April 2011
NCT01420016 Completed N/A Prioritized Clinical Decision Support (CDS) to Reduce Cardiovascular Risk August 20, 2012 August 19, 2014
NCT01426412 Completed Phase 1 A Study of LY3015014 in Healthy Participants With Elevated Low Density Lipoprotein Cholesterol September 2011 June 2013
NCT01442987 Completed Phase 3 Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia May 2011 May 2013
NCT01448174 Completed Phase 4 Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients October 2011 October 2014
NCT01541943 Completed Phase 3 Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia March 2012 November 2014
NCT01550432 Completed N/A Effects of Glutathione (an Antioxidant) and N-Acetylcysteine on Inflammation June 2011 July 2012
NCT01562080 Completed Phase 2/Phase 3 Combined Effects of Bioactive Compounds in Lipid Profile January 2012 October 2012
NCT01569867 Completed Genetic Influences on Statin Blood Concentrations in African Americans March 2012 April 20, 2022
NCT01571609 Completed N/A Baseline Physiology Studies in Carriers of Gene Variant X Conferring Major Risk of CVD-prone Metabolic Disorders August 2012 November 2014
NCT01586897 Completed N/A The Medication Metronome Project - Study to Facilitate Follow-up Testing Resulting From Prescribed Medications to Improve Patient Safety and Care May 2012 May 2013
NCT01597843 Completed N/A Veterans Service Organizations and My HealtheVet (MHV) June 2012 January 2014
NCT01600703 Completed Phase 2/Phase 3 Sitagliptin Regulation of Intestinal and Hepatic Lipoprotein Particle and Hepatic Glucose Production in Humans July 2012 August 2013
NCT01606930 Completed N/A A Pilot Study to Improve Patient-Doctor Communication November 2010 November 2011
NCT01607294 Completed Phase 2 A Single Center Study to Evaluate the Efficacy and Safety of ETC 1002 in Subjects With Type 2 Diabetes April 2012 October 2012
NCT01609907 Completed Phase 1 Pharmacokinetic Drug Interaction Between Rosuvastatin and Valsartan November 2011 May 2012
NCT01634906 Completed N/A Erythrocyte-bound Apolipoprotein B After Withdrawal of Statin Therapy July 2012 March 2013
NCT01642355 Completed N/A Prevention Trial to Achieve Cardiovascular Targets June 2012 May 2016
NCT01644942 Completed N/A Identification in Obese Patients of the Mechanism Involved in Intramuscular Lipid Accumulation May 2008 June 2013
NCT01647438 Completed N/A Translating a Heart Disease Lifestyle Intervention Into the Community August 2012 February 2015
NCT01671254 Completed N/A Effect of Citrus Bioflavonoids/Vitamin E in Conjunction With Fish Oil Supplementation August 2012 December 2012
NCT01678183 Completed N/A Financial Incentives for Medication Adherence September 2012 January 2015
NCT01680211 Completed N/A Safety and Efficacy Study of Herbal Supplements in Prediabetic and Mild to Moderate Hyperlipidemic Patients April 2012 June 2012
NCT01694446 Completed N/A Regulation of Intestinal and Hepatic Lipoprotein Production by Glucose and Fructose September 2011 January 2013
NCT01695954 Completed Phase 1 Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or Efavirenz May 2012 January 2013
NCT01725815 Completed N/A The Health Access and Recovery Peer Program June 2011 March 31, 2017
NCT01739153 Completed N/A Effect of Cheese on Cardiovascular Risk January 2013 November 2014
NCT01761955 Completed Phase 1 Metabolic Health Benefits of Dairy Protein February 2009 May 2011
NCT01763827 Completed Phase 3 Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2 January 21, 2013 October 29, 2013
NCT01763866 Completed Phase 3 LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2 January 15, 2013 December 4, 2013
NCT01763905 Completed Phase 3 Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects -2 January 24, 2013 November 19, 2013
NCT01763918 Completed Phase 3 Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2 February 7, 2013 December 19, 2013
NCT01764178 Completed Phase 1 Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects January 22, 2013 December 27, 2013
NCT01806324 Completed Phase 1 A Study to Evaluate Pharmacokinetics and Potential Drug Interactions of a Fixed-dose Combination Tablet, HL-040XC, in Healthy Male Subjects April 2012 December 2012
NCT01842230 Completed Phase 1 Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine April 2013 July 2013
NCT01842256 Completed Phase 1 Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin. April 2013 July 2013
NCT01845428 Completed Phase 1 Lipid Lowering Agents to Limit Lipid Oxidation and Activation of Clotting System in Nephrotic Syndrome May 2012 January 2017
NCT01858376 Completed N/A Effect Of Capros Supplementation On Cardiovascular Disease Risk Factors In Humans March 2013 January 2015
NCT01865370 Completed Phase 2/Phase 3 Efficacy and Safety of Kochujang Pills on Blood Lipids Profiles in Hyperlipidemia Subjects November 2011 April 2012
NCT01884246 Completed N/A Improving Heart Health in Appalachia August 1, 2013 December 31, 2016
NCT06224296 Not yet recruiting N/A The Exploratory Study About the Effect of Using Double Filtration Plasmapheresis (DFPP) Removing Inflammatory Cytokines, Lipids and Toxic Metal Ions in Peripheral Blood in Adults March 1, 2024 March 1, 2025
NCT05393882 Not yet recruiting Impact of Cholesterol Level on Long-term Coronary Bypass Graft Patency September 1, 2024 December 31, 2027
NCT06422650 Recruiting Phase 2 Effect of Nigella Sativa in Atorvastatin Treated Hyperlipidaemia August 24, 2023 August 31, 2024
NCT06041165 Recruiting Phase 1 A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of JS401 August 31, 2023 September 21, 2024
NCT02262832 Recruiting Phase 3 Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy October 9, 2014 July 31, 2025
NCT05548933 Recruiting Effects of Non-surgical Periodontal Therapy on Severe Periodontitis and Hyperlipidemia September 20, 2022 November 1, 2023
NCT06022575 Recruiting Telehealth Integrated Care Model in Patients With Cardiometabolic Disease June 20, 2023 July 20, 2025
NCT05990595 Recruiting N/A Evaluation of Health Effects of Adlay on Hyperlipidemia and Hyperglycemia Control July 7, 2023 November 30, 2023
NCT06166121 Recruiting N/A Study on Hyperlipidemia Combined With Carotid Atherosclerosis With ShenJu Granules September 20, 2023 December 30, 2023
NCT00231621 Terminated Phase 3 A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With Dyslipidemia May 2001 June 2002
NCT02608242 Terminated Phase 1 PK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and Rosuvastatin November 2015 June 2016
NCT00299169 Terminated Phase 4 Randomized Trial Comparing N of 1 Trials to Standard Practice to Improve Adherence to Statins in Patients With Diabetes September 2006 November 2007
NCT03592355 Terminated N/A Virtual Visits at Brigham and Women's Hospital April 13, 2018 March 1, 2020
NCT00663234 Terminated Phase 1/Phase 2 IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia August 2009 December 2014
NCT00267267 Terminated Phase 3 A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder. January 2006 January 2007
NCT00166166 Terminated Phase 2 Endothelial Hyperpolarization in Humans July 2002 January 2013
NCT00004466 Terminated Phase 2 Pilot Study of Atorvastatin in Children With Chronic Hyperlipidemia Secondary to Nephrotic Syndrome October 1998 December 1999
NCT00477191 Terminated N/A Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis May 2007 December 2013
NCT00267280 Terminated Phase 3 A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol (A5091031). January 2006 December 2006
NCT00640549 Terminated Phase 4 Atorvastatin and LDL Profile in Non-Insulin Dependent Diabetes Mellitus March 2003 October 2004
NCT02952638 Terminated Dietary Sources of Lysophospholipids July 14, 2015 December 2015
NCT02227784 Terminated Phase 3 A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol October 2014 December 2015
NCT00108485 Terminated Phase 3 Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy April 2005 December 2012
NCT00525083 Terminated Protein and Phospholipid Analysis of HDL in Patients With Very High Serum Levels of HDL-C June 2005 November 3, 2014
NCT03884127 Unknown status Ezetimibe and Orlistat Affect the Intestinal Flora of Hyperlipidemia. April 1, 2019 September 30, 2019
NCT04201314 Unknown status N/A Effect of InnoSlim® on Blood Sugar and Blood Lipids Regulation in Humans November 8, 2019 September 30, 2020
NCT04438096 Unknown status Phase 2 Safety and Efficacy of CVI-LM001 in Patients With Hypercholesterolemia July 15, 2020 March 15, 2022
NCT00923676 Unknown status Phase 4 Treatment of Hyperlipidemia and Sexual Dysfunction April 2008 April 2016
NCT00928616 Unknown status N/A Differential Effects of a Diet Supplementation With Plant Sterol Esters on Human Monocytes April 2009 June 2009
NCT01890889 Unknown status N/A Study of Changes in Total Cholesterol Levels as a Function of Consuming a Supplement Designed to Improve Cardiovascular Health July 2013 December 2013
NCT04642742 Unknown status Impact of a Chewable Plant Sterol Supplement on LDL-C in A Real-World Setting November 25, 2020 November 11, 2021
NCT01564875 Unknown status Phase 4 Efficacy and Safety of Simvast Controlled Release (CR) and Zocor in Chronic Kidney Disease(CKD) Stage 3, 4 and 5 Patients With Hyperlipidemia December 2010 May 2012
NCT02959762 Unknown status N/A Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk (Vita-K 'n' Kids Study II) October 2016 December 30, 2020
NCT00518960 Unknown status N/A The Effects of ProAlgaZyme on HDL Cholesterol in Individuals With Metabolic Syndrome April 2007 September 2007
NCT02979704 Unknown status Phase 2/Phase 3 A Comparative Study of Rosuvastatin and Atorvastatin in Patients With Hyperlipidemia September 2016 July 2017
NCT02532218 Unknown status Phase 2 Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia August 2015 December 2016
NCT02992301 Unknown status Phase 4 Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab November 2016 November 2019
NCT00225849 Unknown status Phase 4 Japanese Primary Prevention Project With Aspirin March 2005 September 2010
NCT02087540 Unknown status Phase 3 Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia May 2013
NCT02100202 Unknown status N/A Efficacy and Safety Study of Dietary Supplements in Chronic Smokers Having Mild to Moderate Hyperlipidemia April 2014 July 2014
NCT00626041 Unknown status N/A U-CHAMP: Urban Cardiovascular Health Assessment and Management Program February 2008 June 2011
NCT00627159 Unknown status N/A ICA-CHAMP: Indo-Central Asian Cardiovascular Health Assessment and Management Program May 2007 June 2008
NCT01608620 Unknown status Meta-analyses of Total and Individual Fructose-containing Sugars and Incident Cardiometabolic Disease May 2012 September 2016
NCT02203227 Unknown status N/A Efficacy and Safety Study of Dietary Supplements in Chronic Smokers Having Mild to Moderate Hyperlipidemia August 2014 February 2015
NCT01735149 Unknown status Phase 2/Phase 3 Efficacy and Safety of Kochujang Pills on Improvement of Blood Lipids November 2012 June 2013
NCT00711919 Unknown status N/A Pitavastatin on Carotid Intima-media Thickness July 2007
NCT01752803 Unknown status N/A RCT Examining Effects of Probiotics in T2DM Individuals December 2012 July 2015
NCT00724217 Unknown status Phase 1/Phase 2 Standard Process 21 Day Purification Program Project July 2008 March 2009
NCT00291824 Unknown status Phase 1 Cardiovascular Lifestyle Study: Effects and Expense of a Cardiovascular Risk Reduction Clinic in Primary Care August 2004 February 2006
NCT00316641 Unknown status Phase 3 The Clinical Evaluation of Efficacy of Lipid-Lowing Tea on Hyperlipidemia Patients' Lipid Profiles
NCT00331448 Unknown status Observational Study of Changes in Fat Distribution and Blood Metabolites in HIV Infected Adults June 2000 July 2007
NCT00761904 Unknown status N/A The Effect of Providing Free Samples of Generic Cardiovascular Medications to Physicians December 2010 April 2011
NCT03639480 Unknown status Phase 3 Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia October 13, 2017 October 2018
NCT05255094 Unknown status Phase 3 A Study to Evaluate the Efficacy and Safety of AK102 in Patients With Hyperlipidemia November 3, 2021 July 31, 2022
NCT01798030 Unknown status Vitamin D Retrospective Study and Role With Disease November 2009 December 2022
NCT05255458 Unknown status Phase 3 A Study to Evaluate the Long-term Efficacy and Safety of AK102 in Patients With Hyperlipidemia November 4, 2021 January 31, 2023
NCT00820378 Unknown status The Epidemiology of Aortic Diameter in China January 2009 December 2015
NCT02298894 Unknown status Comparison of LDL Particle Count With Other Available Lipid Tests November 2014 August 2016
NCT01382277 Unknown status Phase 4 Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume March 2011 April 2013
NCT00843661 Unknown status Phase 4 Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-infected Patients March 2009 July 2012
NCT01386853 Unknown status Phase 3 Efficacy and Safety Study of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients July 2011 July 2012
NCT00876330 Unknown status N/A Improving Antihypertensive and Lipid-Lowering Therapy May 2009 March 2013
NCT05260411 Unknown status Phase 3 A Study to Evaluate the Efficacy and Safety of AK102 Q6W in Patients With Hyperlipidemia January 26, 2022 December 31, 2022
NCT00885872 Unknown status Phase 4 Rosuvastatin Evaluation of Atherosclerotic Chinese Patients (REACH) March 2009 March 2012
NCT00408824 Unknown status Investigation of Genetic Risk of Metabolic Syndrome in Company Employee (NGK Study) September 2006
NCT03862183 Unknown status Hospital-level Variation in the Management of Blood Pressure and Low-density Lipoprotein in the Outpatient Hypertensives in China-a Cross Sectional Study July 1, 2017 December 30, 2020
NCT01649986 Unknown status Phase 4 Nutraceuticals to Improve Lipid Profile in European Countries January 2014 December 2017
NCT02147041 Unknown status Phase 2/Phase 3 The Effect of Extract of Green Tea on Obese Women and Obese Related Hormone Peptides May 2012 August 2014
NCT01265160 Unknown status Jiangzhuo Prescription ，Fenofibrate and Placebo in the Treatment of Hyperlipidemia (Syndrome of Phlegm Obstruction)Clinical Study (JZF) November 2010 June 2011
NCT04998981 Unknown status Phase 3 A Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C September 17, 2021 February 2, 2023
NCT01569854 Withdrawn Genetic Influence on Statin Pharmacodynamics March 2012 March 2022
NCT02799758 Withdrawn Phase 3 Efficacy & Long-term Safety Comparison Study of NK-104-CR & Livalo® IR With Primary Hyperlipidemia or Mixed Dyslipidemia February 2016 November 2017
NCT00738985 Withdrawn Phase 4 Efficacy of Ezetimibe/Simvastatin 10/20 mg and MK0524A (1-2 g/Day) in Mixed Hyperlipidemia and Two or More Risk Factors November 2009 September 2010
NCT00572429 Withdrawn N/A Effects of Mixed Exercise Regime and L-Carnitine Supplementation in HIV Patients on HAART July 2008 December 2010
NCT01274104 Withdrawn Phase 1 A Pilot Study on the Effect of Vitamin D Treatment in Patients With Statin-Associated Myalgia October 2010 July 2011
NCT02019680 Withdrawn Study of the Effects of Blackcurrant Extract and Omega-3 Fats on the Health of the Heart and Blood Vessels December 10, 2013 May 9, 2017
NCT02670434 Withdrawn Phase 3 Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia January 2016 October 2017
HPO alt_id (Human Phenotype Ontology)
HP:0008159
HPO alt_id (Human Phenotype Ontology)
HP:0008356
HPO Human Phenotype ID (Human Phenotype Ontology)
HP:0003077